MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice

• Wei Xie ,

  Contributed equally to this work with: Wei Xie, Liang Li, Min Zhang

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China, Laboratory of Clinical Anatomy, University of South China, Hengyang, Hunan, China

  ⨯
• Liang Li ,

  Contributed equally to this work with: Wei Xie, Liang Li, Min Zhang

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China, Department of Pathophysiology, University of South China, Hengyang, Hunan, China

  ⨯
• Min Zhang ,

  Contributed equally to this work with: Wei Xie, Liang Li, Min Zhang

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Hai-Peng Cheng,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Duo Gong,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Yun-Cheng Lv,

  Affiliation Laboratory of Clinical Anatomy, University of South China, Hengyang, Hunan, China

  ⨯
• Feng Yao,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Ping-Ping He,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Xin-Ping Ouyang,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Gang Lan,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Dan Liu,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Zhen-Wang Zhao,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Yu-Lin Tan,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• Xi-Long Zheng,

  Affiliation Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, The University of Calgary, Health Sciences Center, Hospital Dr NW, Calgary, Alberta, Canada

  ⨯
• Wei-Dong Yin ,

  * E-mail: tangchaoke@qq.com (CKT); wdy20042004@126.com (WDY)

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
•  [ ... ],
• Chao-Ke Tang

  * E-mail: tangchaoke@qq.com (CKT); wdy20042004@126.com (WDY)

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan, China

  ⨯
• [ view all ]
• [ view less ]